DJIA 17,084.69 33.94 0.20%
NASDAQ 4,830.47 19.68 0.41%
S&P 500 2,014.89 1.46 0.07%
market minute promo

GlaxoSmithKline (NYSE: GSK)

40.22 0.06 (0.15%)

REAL-TIME: Last trade at

Extended Hours: $40.12 -$0.10 (-0.24%)
Quote as of (NYSE)

company name or ticker

Recent Quotes

GSK $40.22 0.15%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $40.09
Previous Close $40.16
Daily Range $39.86 - $40.33
52-Week Range $37.24 - $49.08
Market Cap $87.3B
P/E Ratio 13.80
Dividend (Yield) $2.31 (6.1%)
Ex-Dividend Date
Dividend Pay Date
Volume 5,235,271
Average Daily Volume 3,452,458
Current FY EPS $2.39




Drug Makers

GlaxoSmithKline (GSK) Description

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products. Website:

News & Commentary

Would an Ebola Vaccine Move Regeneron Pharmaceuticals' Bottom Line?

Regeneron Pharmaceuticals has won a BARDA agreement to develop a potential vaccine for the Ebola virus. How big of a deal is it for Regeneron investors today?

Bristol-Myers to Pay $14M to Settle China Bribe Charges

9 Sector-Leading Dividend Dogs Average 20% Yields As Of September 30

Gilead's Letairis Gets FDA Nod in Combination with Adcirca

3 Drugs Stocks Moving The Industry Upward

Mirna Therapeutics: A Healthy IPO To Start The Week

Clinton Proposals Could Spell Trouble for These 3 Drugmakers

An empowered Medicare program could pressure sales for GlaxoSmithKline, Merck, and Celgene.

3 Stocks We're Ready to Sell

When the market gets choppy, it can be a good time take a hard look at your portfolio.

Glaxo's Eosinophilic Asthma Drug Nucala Wins CHMP Backing

GlaxoSmithKline (GSK) Stock: Is the Worst Over?

See More GSK News...

GSK's Top Competitors

GSK $40.22 (0.15%)
Current stock: GSK
JNJ $95.37 (0.31%)
Current stock: JNJ
PFE $33.24 (0.45%)
Current stock: PFE
NVS $91.90 (-0.77%)
Current stock: NVS